Search

everythinglearnresearchcommunity

for

Search:↓

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Menopause affects hair and skin; more research needed for treatment.

Men with testicular cancer were less likely to experience baldness and severe acne.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Eating isoflavone can help mice grow hair by increasing a growth factor.

Finasteride may help some women with hair loss, but better options exist.

Finasteride for hair loss may cause gynecomastia; doctors should inform patients.